
Merck sees Gardasil China woes carrying into 2025
By Michael Erman and Leroy Leo (Reuters) -Merck & Co said on Thursday that weak sales of Gardasil in China are likely to carry over into 2025 as the vaccine’s distributor there reduces inventories amid low demand, and the U.S. drugmaker’s shares fell 3%. Gardasil, which prevents cancers caused by the human papillomavirus, has been…